Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 387Unknown 194Recruiting 111Terminated 104Not yet recruiting 54Active not recruiting 47Withdrawn 33Suspended 2Enrolling by invitation 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Metastases From Colorectal Cancer (mCRC) 1GI Cancers 1

Interventions

Cisplatin 4130-nm albumin-bound paclitaxel 3camrelizumab 2Oxaliplatin 2Nivolumab 2Magnetic Resonance Spectroscopy 2Laparoscopy 2Bevacizumab 2trilaciclib 1trastuzumab deruxtecan 1toripalimab 1selinexor 1sacituzumab govitecan 1ribociclib 1olaparib 1nimotuzumab 1lenvatinib 1fluorodopa F 18 1durvalumab 1decitabine and cedazuridine drug combination 1dalpiciclib 1cemiplimab 1carfilzomib 1apatinib 1anlotinib 1abemaciclib 1Valacyclovir 1Temozolomide 1Taxes 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Enrolling by invitation × Oxaliplatin × Clear all
NCT07441369 2026-04-27

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Fudan University

Phase 2 Enrolling by invitation
16 enrolled
Gastrointestinal

Liver Metastases From Colorectal Cancer (mCRC)

NCT06648785 2026-02-05

Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients With GI Malignancies

University of Vermont Medical Center

Phase 2 Enrolling by invitation
20 enrolled

GI Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡